Osamu Iritani
Overview
Explore the profile of Osamu Iritani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kainuma M, Kawakatsu S, Kim J, Ouma S, Iritani O, Yamashita K, et al.
Front Pharmacol
. 2023 Jun;
14:1203349.
PMID: 37377927
Alzheimer's disease (AD), the most prevalent form of dementia, is a debilitating, progressive neurodegeneration. Amino acids play a wide variety of physiological and pathophysiological roles in the nervous system, and...
2.
Demura T, Okuno T, Miwa T, Iritani O, Nakano H, Yamamoto J, et al.
Geriatr Gerontol Int
. 2022 Dec;
23(1):16-24.
PMID: 36527175
Aim: Although sarcopenia is common in patients with Alzheimer's disease (AD), the neural substrates involved remain unclear. We investigated the relationship between sarcopenia, as well as its definition components, and...
3.
Higashikawa T, Shigemoto K, Moriyama M, Usuda D, Hangyou M, Inujima H, et al.
J Orthop Sci
. 2022 Nov;
29(1):273-277.
PMID: 36446671
Background: This study aimed to evaluate the effects of orthogeriatric co-management of hip fractures at a regional core hospital. Methods: This study included patients with proximal hip fracture. Patients were...
4.
Kainuma M, Ouma S, Kawakatsu S, Iritani O, Yamashita K, Ohara T, et al.
Front Pharmacol
. 2022 Oct;
13:991982.
PMID: 36313371
Alzheimer's disease (AD) is a progressive neurodegeneration and is the most prevalent form of dementia. Intervention at an early stage is imperative. Although three acetylcholinesterase inhibitors (AChEIs) are currently approved...
5.
Okuno T, Iritani O, Kodera K, Hama D, Kane A, Morigaki K, et al.
Geriatr Gerontol Int
. 2022 May;
22(7):541-542.
PMID: 35562122
No abstract available.
6.
Okuno T, Iritani O, Kodera K, Hama D, Kane A, Morigaki K, et al.
Geriatr Gerontol Int
. 2022 Mar;
22(5):457-458.
PMID: 35322529
No abstract available.
7.
Hamada K, Tateishi J, Sugiki S, Ishisaka T, Igarashi Y, Kodera K, et al.
Geriatr Gerontol Int
. 2021 Jul;
21(9):865-866.
PMID: 34250707
No abstract available.
8.
Hamada K, Itoh T, Kawaura K, Kuno H, Kamai J, Kobayasi R, et al.
World J Oncol
. 2021 May;
12(2-3):67-72.
PMID: 34046101
A 77-year-old man who underwent radiotherapy for hepatocellular carcinoma 6 months prior consulted for esophageal obstruction. Esophagogastroduodenoscopy revealed an esophageal ulcer caused by radiotherapy for hepatocellular carcinoma. He was treated...
9.
Hamada K, Itoh T, Kawaura K, Kitakata H, Kuno H, Kamai J, et al.
J Clin Med Res
. 2021 May;
13(4):222-229.
PMID: 34007360
Background: Endoscopic ultrasonography (EUS) is one of the helpful tools to diagnose depth of early gastric cancer (EGC). In this study, we examined efficiencies of EUS for EGC such as...
10.
Ishisaka T, Igarashi Y, Kodera K, Okuno T, Morita T, Himeno T, et al.
J Clin Med Res
. 2021 Feb;
13(1):73.
PMID: 33613802
[This corrects the article DOI: 10.14740/jocmr4330.].